Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kahn, S. E.
Right arrow Articles by Porte, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahn, S. E.
Right arrow Articles by Porte, D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 38, Issue 5 562-568, Copyright © 1989 by American Diabetes Association


ARTICLES

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

SE Kahn, JC Beard, MW Schwartz, WK Ward, HL Ding, RN Bergman, GJ Taborsky and D Porte
Department of Medicine, University of Washington School of Medicine, Seattle.

To determine whether prolonged nicotinic acid (NA) administration produces insulin resistance and, if so, how the normal pancreatic islet adapts to prolonged insulin resistance, we administered incremental doses of NA to 11 normal men for 2 wk, ending at 2 g/day. Insulin sensitivity was measured with Bergman's minimal model. Islet function was evaluated by measurement of acute insulin (AIR) and glucagon (AGR) responses to arginine at three glucose levels. Insulin resistance was demonstrated and quantified by a marked drop in the insulin sensitivity index (Sl) from 6.72 +/- 0.77 to 2.47 +/- 0.36 x 10(-5) min-1/pM (P less than .0001) and resulted in a doubling of basal immunoreactive insulin levels (from 75 +/- 7 to 157 +/- 21 pM, P less than .001) with no change in fasting glucose (5.5 +/- 0.1 vs. 5.7 +/- 0.1 mM). Proinsulin levels also increased (from 9 +/- 1 to 15 +/- 2 pM, P less than .005), but the ratio of proinsulin to immunoreactive insulin did not change (12.7 +/- 1.9 vs. 10.3 +/- 1.9%). beta-Cell changes were characterized by increases in the AIR to glucose (from 548 +/- 157 to 829 +/- 157 pM, P less than .005) and in the AIR to arginine at the fasting glucose level (from 431 +/- 54 to 788 +/- 164 pM, P less than .05). At the maximal hyperglycemia level the AIR to arginine represents beta-cell secretory capacity, and this increased with administration of NA (from 2062 +/- 267 to 2630 +/- 363 pM, P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Cheng, P. K. Law, M. de Gasparo, and P. S. Leung

J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 683 - 691.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Chang, M. J. Smith, A. T. Galecki, C. J. Bloem, and J. B. Halter
Impaired {beta}-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3303 - 3309.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Rasouli, T. Hale, S. E. Kahn, H. J. Spencer, and S. C. Elbein
Effects of Short-Term Experimental Insulin Resistance and Family History of Diabetes on Pancreatic {beta}-Cell Function in Nondiabetic Individuals
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5825 - 5833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Smith, L. E. Porter, N. Biswas, and M. I. Freed
Rosiglitazone, But Not Glyburide, Reduces Circulating Proinsulin and the Proinsulin:Insulin Ratio in Type 2 Diabetes
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6048 - 6053.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. E. Roder and S. E. Kahn
Suppression of Beta-Cell Secretion by Somatostatin Does Not Fully Reverse the Disproportionate Proinsulinemia of Type 2 Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S22 - S25.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. L. Teff and R. R. Townsend
Prolonged Mild Hyperglycemia Induces Vagally Mediated Compensatory Increase in C-Peptide Secretion in Humans
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5606 - 5613.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Utzschneider, D. B. Carr, S. M. Barsness, S. E. Kahn, and R. S. Schwartz
Diet-Induced Weight Loss Is Associated with an Improvement in {beta}-Cell Function in Older Men
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2704 - 2710.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. D. Meyers, M. C. Carr, S. Park, and J. D. Brunzell
Varying Cost and Free Nicotinic Acid Content in Over-the-Counter Niacin Preparations for Dyslipidemia
Ann Intern Med, December 16, 2003; 139(12): 996 - 1002.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
References
Circulation, December 17, 2002; 106(25): 3373 - 3421.
[Full Text]


Home page
JAMAHome page
P. G. Yeni, S. M. Hammer, C. C. J. Carpenter, D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, et al.
Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel
JAMA, July 10, 2002; 288(2): 222 - 235.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. S. Choi, F. N. Lee, A. A. McDonough, and J. H. Youn
Independent Regulation of In Vivo Insulin Action on Glucose Versus K+ Uptake by Dietary Fat and K+ Content
Diabetes, April 1, 2002; 51(4): 915 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Kahn
The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. M. Steil, N. Trivedi, J.-C. Jonas, W. M. Hasenkamp, A. Sharma, S. Bonner-Weir, and G. C. Weir
Adaptation of {beta}-cell mass to substrate oversupply: enhanced function with normal gene expression
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E788 - E796.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. E. Kahn, R. L. Prigeon, R. S. Schwartz, W. Y. Fujimoto, R. H. Knopp, J. D. Brunzell, and D. Porte Jr.
Obesity, Body Fat Distribution, Insulin Sensitivity and Islet {{beta}}-Cell Function as Explanations for Metabolic Diversity
J. Nutr., February 1, 2001; 131(2): 354S - 360.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. S. Choi, C. B. Thompson, P. K. K. Leong, A. A. McDonough, and J. H. Youn
Short-term K+ deprivation provokes insulin resistance of cellular K+ uptake revealed with the K+ clamp
Am J Physiol Renal Physiol, January 1, 2001; 280(1): F95 - F102.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. B. Elam, D. B. Hunninghake, K. B. Davis, R. Garg, C. Johnson, D. Egan, J. B. Kostis, D. S. Sheps, E. A. Brinton, and for the ADMIT Investigators
Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease: The ADMIT Study: A Randomized Trial
JAMA, September 13, 2000; 284(10): 1263 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Q. Liu, P. W. Nevin, and J. L. Leahy
beta -Cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E68 - E73.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Oberman
Hypertriglyceridemia and Coronary Heart Disease
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2098 - 2105.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Røder, R. S. Schwartz, R. L. Prigeon, and S. E. Kahn
Reduced Pancreatic B Cell Compensation to the Insulin Resistance of Aging: Impact on Proinsulin and Insulin Levels
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2275 - 2280.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. J. Kaiyala, R. L. Prigeon, S. E. Kahn, S. C. Woods, D. Porte Jr., and M. W. Schwartz
Reduced beta -cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding
Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E659 - E667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. J. Dechenes, C. B. Verchere, S. Andrikopoulos, and S. E. Kahn
Human aging is associated with parallel reductions in insulin and amylin release
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E785 - E791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. K. Krishnan, J. M. Hernandez, D. L. Williamson, D. J. O'Gorman, W. J. Evans, and J. P. Kirwan
Age-related differences in the pancreatic beta -cell response to hyperglycemia after eccentric exercise
Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E463 - E470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. L. Prigeon, S. E. Kahn, and D. Porte Jr.
Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 819 - 823.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Røder, D. Porte Jr., R. S. Schwartz, and S. E. Kahn
Disproportionately Elevated Proinsulin Levels Reflect the Degree of Impaired B Cell Secretory Capacity in Patients with Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 604 - 608.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Ahren and G. Pacini
Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E701 - E707.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1989 by the American Diabetes Association.